Rating: HOLD
| Metric | Value |
|---|---|
| Current Price | $279 |
| Triangulated Fair Value | $229 |
| 12-mo Scenario PWEV | $285 |
| Implied Return | -18% |
| Forward P/E | 33.2x |
| Market Cap | $78B |
| 52-Week Range | $242 – $308 |
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.
Investment Thesis
The bull case — 'Bull — Cycle + Re-Rate' (8% weight) — targets $505, +81% vs spot. It needs the multiple to hold or expand.
The dashboard below is the whole argument on one page: spot ($279) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural case — 'Structural — Brand / Volume Erosion' (20%) — targets $122, -56% vs spot. This sits below the 52-week low — a genuine structural impairment, not a mild pullback.
Key Debate
P/E Multiple explains 53% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.77 vs analyst floor +0.00 → delta +0.77 (n=29 mgmt / 20 Q&A; 99th pctile across the S&P book, z +2.3).
Flag: ELEVATED — management unusually upbeat vs the analyst floor relative to peers (disconfirmation watch).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.77 | +0.00 | +0.77 |
| 2025Q4 | +0.44 | +0.16 | +0.28 |
| 2025Q3 | +0.44 | +0.18 | +0.26 |
| 2025Q2 | +0.38 | -0.02 | +0.40 |
News (last 365d, 1000 articles): avg ticker sentiment +0.23 (bullish 34% / bearish 2%)
Scenario Analysis
The tree runs from a structural 'Structural — Brand / Volume Erosion' downside ($122) to a 'Bull — Cycle + Re-Rate' bull case ($505); the probability-weighted blend (PWEV $285) is +2% versus spot.
| Scenario | Probability | Target | Return |
|---|---|---|---|
| Structural — Brand / Volume Erosion | 20% | $122 | -56% |
| Downturn — Construction / Industrial Slump | 18% | $213 | -23% |
| Base — Pricing-Led Compounding | 33% | $296 | +6% |
| Growth — Share Gains + Mix | 21% | $400 | +44% |
| Bull — Cycle + Re-Rate | 8% | $505 | +81% |
| Probability-Weighted (PWEV) | — | $285 | +2% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Brand / Volume Erosion (20%, $122). Structural impairment — raw-material squeeze / volume loss: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 122.23; probability: 0.2.
- Downturn — Construction / Industrial Slump (18%, $213). Cyclical downturn — coatings/specialty volumes + raw-material spread + pricing power weakens for 1–2 years before normalising. Drivers — implied_target: 213.24; probability: 0.18.
- Base — Pricing-Led Compounding (33%, $296). Mid-cycle — normalised coatings/specialty volumes + raw-material spread + pricing power; disciplined capital allocation; steady returns. Drivers — implied_target: 296.16; probability: 0.33.
- Growth — Share Gains + Mix (21%, $400). Upside — share gains + input deflation lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 399.82; probability: 0.21.
- Bull — Cycle + Re-Rate (8%, $505). Upside tail — sustained tight conditions or a structural re-rate on share gains + input deflation. Drivers — implied_target: 504.96; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $254 | -9% |
| Peer P/E re-rate | multiple | $151 | -46% |
| Peer EV/Revenue re-rate | multiple | $125 | -55% |
| Scenario PWEV | multiple | $285 | +2% |
| DCF (5-year + terminal) | cash flow + terminal × | $202 | -28% |
| Triangulated (weighted) | — | $229 | -18% |
Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $254 + scenario PWEV $285, ≈ spot); the weighted blend $229 (-18%) sits below it because the cash-flow DCF ($202) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $254 and 41% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (53% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 8.5%, 29x terminal FCF multiple → $202. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 18.015x) implies $151. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is wide (genuine disagreement — low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|
| Specialty Chemicals / Coatings | $16.4B | 100% | 5% | 18% | 34x | 4% | ESTIMATE |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | coatings/specialty volumes + raw-material spread + pricing power |
| net_debt_or_cash_b | -8.75 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.04 |
| div_yield | 0.01 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | raw-material squeeze / volume loss |
| upside | share gains + input deflation |
Industry Context — Materials — Quality
This name sits in the Materials — Quality as a coatings. coatings/specialty volumes + raw-material spread + pricing power Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: LIN (gases) · SHW (coatings) · ECL (coatings) · APD (gases) · CTVA (ag_specialty) · PPG (coatings) · IFF (coatings) · DD (coatings)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Industrial Recession — Demand / De-Rate | 38% | 38% | |
| Mid-Cycle — Steady Compounding | 33% | 33% | |
| Expansion — Volume + Pricing Upside | 29% | 29% |
On the cluster's key downside — Industrial Recession — Demand / De-Rate () — this name implies 38% vs the cluster house view of 38% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The quality cycle is the shared macro driver. Driver — global industrial demand + pricing power (gases, coatings, specialty/ag) Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $17B | $3B | $1B | $1B | $2B | $2B |
| FY+2 | $18B | $3B | $1B | $1B | $3B | $2B |
| FY+3 | $19B | $4B | $1B | $1B | $3B | $2B |
| FY+4 | $20B | $4B | $1B | $1B | $3B | $2B |
| FY+5 | $20B | $4B | $1B | $1B | $3B | $2B |
| Terminal | — | — | — | — | $3B × 29x | $55B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 8.5% · Σ PV(FCF) $10B + PV(terminal) $55B = EV $65B; + net cash → equity $57B ÷ diluted shares 0.28B = $202/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $121/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 14% vs WACC 8% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| SHW | 4.061x | 28.82x | 5% | 14% |
| PPG | 2.071x | 15.46x | 5% | 14% |
| IFF | 2.321x | 16.69x | 5% | 10% |
| DD | 3.045x | 19.34x | 5% | 14% |
| Median | 2.683x | 18.015x | — | — |
Peer-median fwd P/E → $151; EV/Rev → $125.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $202 | 41% | $83 |
| Scenario PWEV | $285 | 29% | $84 |
| Monte Carlo median | $254 | 18% | $45 |
| Peer P/E | $151 | 12% | $18 |
| Triangulated | — | 100% | $229 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 20.3x | 24.6x | 29.0x | 33.3x | 37.7x |
|---|---|---|---|---|---|
| 6% | $159 | $190 | $223 | $255 | $288 |
| 8% | $151 | $181 | $212 | $243 | $274 |
| 8% | $143 | $172 | $202 | $231 | $261 |
| 10% | $136 | $164 | $192 | $220 | $248 |
| 10% | $129 | $156 | $183 | $209 | $237 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $142 | $159 | $176 | $192 | $209 |
| -1.5pp | $153 | $171 | $188 | $206 | $224 |
| +0.0pp | $164 | $183 | $202 | $221 | $240 |
| +1.5pp | $175 | $196 | $216 | $236 | $257 |
| +3.0pp | $188 | $209 | $231 | $253 | $275 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $164 | $240 | $76 |
| Terminal × ±15% | $172 | $231 | $59 |
| Revenue CAGR ±3pp | $176 | $231 | $55 |
| WACC ±1pp | $192 | $212 | $20 |
| FCF conversion ±10% | $202 | $202 | $0 |
Company lever — SoP/share vs Specialty Chemicals / Coatings multiple (AI re-rating) (base 34x)
| Multiple | 23.8x | 28.9x | 34.0x | 39.1x | 44.2x |
|---|---|---|---|---|---|
| SoP/share | $1,358 | $1,656 | $1,953 | $2,251 | $2,549 |
Load-Bearing Assumptions
DCF: WACC 8%, terminal multiple 29×, FY+5 revenue $20B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
The valuation is multiple-dependent (53% of variance); a de-rating toward the DCF anchor ($202) implies -28%.
Fact / Inference / Speculation
- FACT: Spot $279; 52-week range $242–$308; engine rating HOLD; base-case target $285 (+2%).
- INFERENCE: Triangulated FV $229 (-18%). P/E Multiple explains 53% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
- SPECULATION: At current prices the embedded bet is that the multiple holds or expands — P/E Multiple carries 53% of outcome variance.
Recommendation: HOLD
Balanced: triangulated fair value $229 (-18% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple (53% of variance) — fundamentally a multiple/regime call. SBC runs —M TTM (disclosed in the appendix).